Here are the S-3 shelf registrations from Lakeside Holding Limited (LSH) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-3 covers the shelf registration that lets an established company sell over time, so if you follow LSH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full LSH filings page.
Quanome Technologies, Inc., a Nevada holding company with PRC-based operations, has filed a shelf registration to offer up to $120,000,000 of common stock, preferred stock, debt securities, warrants, rights and units from time to time. The company’s common stock trades on Nasdaq under the symbol QNME.
As of August 4, 2026, public float was approximately $21,980,437, based on 31,726,959 non-affiliate shares out of 34,427,559 shares outstanding at a price of $0.6928 per share, and sales under this registration are subject to the baby shelf limitation of not exceeding one-third of public float in any 12-month period while float remains below $75 million.
Operations currently center on pharmaceutical distribution in China through wholly owned PRC subsidiary Hupan Pharmaceutical, with early-stage plans for quantum-enabled AI and post-quantum cryptography via Quantum Nexus and inactive digital-asset entities. The filing highlights extensive PRC legal, regulatory, data-security and capital-controls risks, HFCAA-related audit and delisting risks, and a Nasdaq minimum bid-price deficiency for which Quanome has a second compliance period through January 4, 2027, potentially requiring a reverse stock split.
Lakeside Holding Limited filed a shelf registration on Form S-3 to offer up to $120,000,000 aggregate of common stock, preferred stock, debt securities, warrants, rights and units from time to time. The prospectus is a base shelf; specific offerings will be described in prospectus supplements.
The company states its common stock trades on Nasdaq under the symbol LSH, with a closing price of $0.4198 per share on July 7, 2026. As of the date of this prospectus, 34,427,559 shares of common stock are issued and outstanding. The prospectus discloses Nasdaq non-compliance with the $1.00 minimum bid price and notes a compliance period ending July 7, 2026.